North America Artesunate Market Size & Outlook, 2026-2034


North America Artesunate Market Insights

  • According to Reed Intelligence analysis, the North America Artesunate Market size stood at USD 158.29 Million in 2025 and is forecasted to reach USD 288.84 Million by 2034.
  • The market is projected to grow at a CAGR of 6.92% between 2026 and 2034.
  • By segment, Injectable Artesunate was the leading Formulation in terms of market size in 2025.
  • Oral Artesunate is expected to be the most lucrative Formulation segment, exhibiting the fastest growth throughout the forecast period.

Other Key Findings


  • In 2025, North America accounted for 30.44% of the global Artesunate Market size.
  • By 2034, United States is projected to lead the global market in terms of market size.
  • United States is projected to emerge as the fastest-growing market in North America, reaching USD 227.66 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 158.29 Million
Market Size In 2034 USD 288.84 Million
Largest segment Injectable Artesunate
Units Revenue in USD Million
CAGR 6.92% (2026-2034)
Segmnetation Covered
North America
  1. United States
  2. Canada
Formulation
  1. Injectable Artesunate
  2. Oral Artesunate
Application
  1. Severe Malaria Treatment
  2. Uncomplicated Malaria Treatment
End-Use
  1. Hospitals
  2. Clinics
  3. Retail Pharmacies
Distribution Channel
  1. Government Supply Programs
  2. Private Sector Distribution
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends